MoneyWorks4Me

USFDA inspects Divis Laboratories’ Unit-I at Hyderabad

21 Jun 2014 Evaluate

Divis Laboratories’ Unit-I at Lingojigudem village, Choutuppal Mandal near Hyderabad has been successfully inspected by the USFDA from June 16-20, 2014, without any observations. The purpose of this inspection was for general Current Good Manufacturing Practices for the facility.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..